BASF to Pay $654 Million for Pronova

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

BASF SE agreed to buy Pronova BioPharma ASA in a transaction valuing the Norwegian company at 3.76 billion kroner ($654 million) to gain a leading position in Omega-3 fatty acids used in drugs and health foods.

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change